Latest

Market news by symbol, source, and language

20 stories
globenewswire

Cycurion Receives Nasdaq Delisting Determination Letter; Appeal Underway, Trading to Continue, Focus on Shareholder Value

MCLEAN, Va., July 16, 2026 (GLOBE NEWSWIRE) -- Cycurion, Inc. NASDAQ:CYCU (“Cycurion” or the “Company”), a leading AI driven, tech-enabled cybersecurity solutions provider, today announced that it has received a delisting determination letter from The Nasdaq Stock Market LLC (“Nasdaq”) related to i…

GlobeNewswire en_IN
StocksUS
prnewswire

Omnicom Declares Dividend

NEW YORK, July 16, 2026 /PRNewswire/ -- The Board of Directors of Omnicom (NYSE:OMC) declared a quarterly dividend of 80 cents per outstanding share of the corporation's common stock. The dividend is payable on October 9, 2026 to Omnicom common shareholders of record at the close of business on Sep…

PR Newswire en_IN
StocksUS
stocktwits

GOOGL Stock Falls 5% As Google’s Flagship AI Model Reportedly Runs Behind Schedule — Why Retail Traders Aren’t Worried

Alphabet Inc. (GOOGL) shares sank nearly 5% on Thursday after a report said Google is months behind schedule in releasing Gemini 3.5 Pro, its flagship artificial intelligence model. The report added that the company has delayed the launch as it works to improve the model’s capabilities, particularl…

Stocktwits en_IN
StocksUS
tradingview

Cosmos Health elects Grigorios Siokas and Demetrios G. Demetriades to board

Cosmos Health elected six directors at its 2026 Annual Meeting, including Grigorios Siokas and Demetrios G. Demetriades.Original SEC Filing: Cosmos Health Inc. [ COSM ] - 8-K - Jul. 16, 2026This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the…

TradingView en_IN
StocksUS
tradingview

Gyre Therapeutics appoints Yue Xiong, Maxwell Kirkby and Claire Weston to its Board

Gyre Therapeutics appointed Yue Xiong, Ph.D., Maxwell Kirkby and Claire Weston, Ph.D. to its Board effective August 1, 2026.Original SEC Filing: GYRE THERAPEUTICS, INC. [ GYRE ] - 8-K - Jul. 16, 2026This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information…

TradingView en_IN
StocksUS
business_wire

MP Materials Announces Date for Second Quarter 2026 Financial Results and Webcast

MP Materials Corp. (NYSE: MP) will release its financial results for the second quarter ended June 30, 2026, after the U.S. markets close on Thursday, August 6, 2026.MP Materials’ management will host a conference call and webcast that afternoon at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time). P…

BusinessWire en_IN
StocksUS
acceswire

Protagonist Therapeutics Reports Granting of Inducement Awards

NEWARK, CA / ACCESS Newswire / July 16, 2026 / Protagonist Therapeutics, Inc. NASDAQ:PTGX today reported that on July 15, 2026, it granted inducement awards to three recently hired employees in accordance with the terms of their employment offer letters. The awards were granted under the Protagonis…

ACCESS Newswire en_IN
ETFsStocksUS
prnewswire

FIRST FINANCIAL BANKSHARES ANNOUNCES SECOND QUARTER 2026 EARNINGS

ABILENE, Texas, July 16, 2026 /PRNewswire/ -- First Financial Bankshares, Inc. (the "Company," "we," "us" or "our") (NASDAQ:FFIN) today reported earnings of $71.89 million for the second quarter of 2026 compared to earnings of $66.66 million for the same quarter a year ago and $71.54 million for th…

PR Newswire en_IN
StocksUS
prnewswire

Genpact Limited Board Declares Quarterly Cash Dividend

NEW YORK, July 16, 2026 /PRNewswire/ -- Genpact (NYSE:G), an agentic and advanced technology solutions company recognized for its deep industry knowledge, process intelligence, and last-mile expertise, today announced that its board of directors has declared a cash dividend of $0.1875 per common sh…

PR Newswire en_IN
StocksUS
globenewswire

Gyre Therapeutics Appoints Three New Members to its Board of Directors

SAN DIEGO, July 16, 2026 (GLOBE NEWSWIRE) -- Gyre Therapeutics, Inc. (“Gyre”, “Gyre Therapeutics” or the “Company”) NASDAQ:GYRE, an innovative, commercial-stage biopharmaceutical company with operations in the United States and China, today announced that its Board of Directors has appointed three…

GlobeNewswire en_IN
StocksUS